BRIEF-Pfizer, Astellas report positive top-line results from phase 3 PROSPER trial of XTANDI

* Pfizer and Astellas announce positive top-line results from phase 3 prosper trial of XTANDI (enzalutamide) in patients with non-metastatic castration-resistant prostate cancer

Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

See also

One dead, dozens injured in cosmetics factory explosions

A man is killed and dozens of other workers and firefighters are injured in two explosions and a fire at a New York cosmetics factory, which has been cited for nine occupational safety violations this year.

0 0

Whoops, looks like something went wrong.